01/24/2025
3:17 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
01/22/2025
7:45 AM | Aerovate Therapeutics (Filer)
| Form S-4/A | |
01/13/2025
4:24 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
12/03/2024
5:27 AM | Aerovate Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/18/2024
4:29 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
8:27 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:29 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
Get the Latest News and Ratings for AVTE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/17/2024
3:59 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:04 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:31 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
7:00 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
5:00 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
06/20/2024
4:56 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:35 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:44 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:00 PM | Aerovate Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
7:29 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:57 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:39 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:59 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
3:16 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024
4:23 PM | Aerovate Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:18 AM | Aerovate Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:19 AM | Aerovate Therapeutics (Filer)
| Form DEFA14A | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:25 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:42 PM | Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:18 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
6:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:31 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
8:22 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:15 PM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:12 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:35 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:37 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
2:28 PM | Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:34 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
